Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Gains from Sales and Divestitures: 2019-2023

Historic Gains from Sales and Divestitures for Bicycle Therapeutics (BCYC) over the last 3 years, with Dec 2023 value amounting to $119,144.

  • Bicycle Therapeutics' Gains from Sales and Divestitures rose 240.41% to $119,144 in Q4 2023 from the same period last year, while for Dec 2023 it was $119,144, marking a year-over-year increase of 240.41%. This contributed to the annual value of $119,144 for FY2023, which is 240.41% up from last year.
  • Latest data reveals that Bicycle Therapeutics reported Gains from Sales and Divestitures of $119,144 as of FY2023, which was up 240.41% from $35,000 recorded in FY2022.
  • Bicycle Therapeutics' Gains from Sales and Divestitures' 5-year high stood at $119,144 during FY2023, with a 5-year trough of $35,000 in FY2022.
  • Moreover, its 2-year median value for Gains from Sales and Divestitures was $77,072 (2022), whereas its average is $77,072.
  • Data for Bicycle Therapeutics' Gains from Sales and Divestitures shows a peak YoY skyrocketed of 240.41% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Bicycle Therapeutics' Gains from Sales and Divestitures stood at $83,947 in 2019, then reached $35,000 in 2022, then surged by 240.41% to $119,144 in 2023.